INSMED INC Deferred Tax Liabilities, Gross
INSMED INC (INSM) had Deferred Tax Liabilities, Gross of $7.13 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-19
- 2025-12-31: Deferred Tax Liabilities, Gross $7.13M.
- 2024-12-31: Deferred Tax Liabilities, Gross $12.53M.
- 2023-12-31: Deferred Tax Liabilities, Gross $18.72M; Deferred Tax Liabilities, Gross as first filed $22.59M.
- 2022-12-31: Deferred Tax Liabilities, Gross $24.97M.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $7.13M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $12.53M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $18.72M 10-K · filed 2025-02-20 | $22.59M 10-K · filed 2024-02-22 |
| 2022-12-31 | $24.97M 10-K · filed 2024-02-22 | |
| 2021-12-31 | $79.97M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $42.69M 10-K · filed 2022-02-17 | |
| 2019-12-31 | $58.33M 10-K · filed 2021-02-25 | $41.89M 10-K · filed 2020-02-25 |
| 2018-12-31 | $48.22M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $16.36M 10-K · filed 2019-02-22 | |
| 2016-12-31 | $23.25M 10-K · filed 2018-02-23 | |
| 2015-12-31 | $23.25M 10-K · filed 2017-02-23 | |
| 2014-12-31 | $23.25M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $23.25M 10-K · filed 2015-02-27 | |
| 2012-12-31 | $22.09M 10-K · filed 2014-03-06 | |
| 2011-12-31 | $22.26M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |